In 2022, it’s estimated that 9,910 new cases of testicular cancer will be diagnosed in the United States, according to the American Cancer Society.1 This April, for Testicular Cancer Awareness Month, we’re highlighting some key information to help raise awareness and encourage education – read on for five important things to know about testicular cancer. […]
Search Results for: log in
15
Apr
Apr
The birds and the bees are buzzing in April with the arrival of spring – what better time to bring sexual health into the conversation for STI Awareness Month. Whether you call them sexually transmitted infections (STI) or sexually transmitted diseases (STD) – it’s important to talk about this crucial component of sexual and overall […]
LabPulse.com Healthcare technology company Cue Health and BioReference Laboratories have announced that the Cue Clinic dashboard point-of-care solution will be made available to BioReference’s clinical customers, including healthcare providers and point-of-care clinics in the U.S., as part of BioReference’s product lineup. The Cue Clinic dashboard offers analytics, reporting solutions, and application programming interface (API) integrations […]
06
Apr
Apr
Spring is here, bringing blooming flowers, budding trees and for many Americans – the allergies that come along with them. While allergy sufferers may chalk their symptoms up to usual suspects like hay fever, multiple allergies could be at play that can affect your body’s response. Here, we examine some seasonal allergy basics, the symptom […]
Press Release
Cue Health and BioReference Laboratories Bring Point-of-Care Solutions to the Clinical Setting
05
Apr
Apr
Cue Health debuts Cue Clinic™ dashboard to give healthcare providers more choice and control over patient care as part of BioReference’s product offering SAN DIEGO and ELMWOOD PARK, N.J., April 5, 2022 /PRNewswire/ — Cue Health Inc. (“Cue”) (Nasdaq: HLTH), the healthcare technology company behind one of the country’s most accurate COVID-19 tests and BioReference Laboratories, Inc., an OPKO Health company (“BioReference”), today announced […]
29
Mar
Mar
As part of Women’s History Month, Jewell shares her perspective on the mothers of modern gynecology, her family’s history, and the demand for change in women’s rights through our BioDiversity & Inclusion: myPerspective series By Jewell, Specimen Processing Department The “Mothers of Modern Gynecology”[i] are omitted from medical textbooks. There are no beautiful Black busts […]
17
Mar
Mar
Embracing her Irish roots, Nuala celebrates St. Patrick’s Day by sharing her family story and childhood memories through our BioDiversity & Inclusion: myPerspective series By Nuala, Logistics Department As St. Patrick’s Day approaches, I hear chatter from colleagues concerning the joys of Irish soda bread and the marvels of Guinness stout. For me, personally, these […]
11
Mar
Mar
If you are newly pregnant or considering family planning, noninvasive prenatal screening (NIPS) is likely a term you’ve come across. While NIPS can be an important factor in learning more about your developing baby’s health, genetic testing during pregnancy may seem complex. Here, we’re breaking down some basic information about this screening process and your […]
01
Mar
Mar
Each year, the first Friday in March marks National Dress in Blue Day – presenting the opportunity to wear blue and raise awareness for colorectal cancer. This year, join the Colorectal Cancer Alliance’s mission to help end this disease and commit to learning more about its screening and prevention. Go Blue for Colorectal Cancer Awareness […]
25
Feb
Feb
As the showdown between Cincinnati and Los Angeles kicked off just a few weeks ago, the game also marked a milestone for the BioReference team. From hours spent planning logistics to around-the-clock testing and traveling with teams, BioReference has been at the forefront of the pandemic sports game plan since the beginning. We’re sharing a […]
